0001493152-24-022082.txt : 20240531 0001493152-24-022082.hdr.sgml : 20240531 20240531080025 ACCESSION NUMBER: 0001493152-24-022082 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240531 DATE AS OF CHANGE: 20240531 EFFECTIVENESS DATE: 20240531 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MyMD Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001321834 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-514757 FILM NUMBER: 241007738 BUSINESS ADDRESS: STREET 1: 855 N. WOLFE STREET STREET 2: SUITE 601 CITY: BALTIMORE STATE: MD ZIP: 21205 BUSINESS PHONE: 856-848-8698 MAIL ADDRESS: STREET 1: 855 N. WOLFE STREET STREET 2: SUITE 601 CITY: BALTIMORE STATE: MD ZIP: 21205 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences, Inc. DATE OF NAME CHANGE: 20170413 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences Inc DATE OF NAME CHANGE: 20050325 D 1 primary_doc.xml X0708 D LIVE 0001321834 MyMD Pharmaceuticals, Inc. 855 N. WOLFE STREET SUITE 623 BALTIMORE MD MARYLAND 21205 856-848-8698 DELAWARE None Akers Biosciences, Inc. Akers Biosciences Inc Corporation true 2023 Chris Chapman 855 N. Wolfe Street Suite 623 BALTIMORE MD MARYLAND 21205 Executive Officer President, Chief Medical Officer, and Director Ian Rhodes 855 N. Wolfe Street Suite 623 BALTIMORE MD MARYLAND 21205 Executive Officer Chief Financial Officer Craig Eagle 855 N. Wolfe Street Suite 623 BALTIMORE MD MARYLAND 21205 Director Christopher Schreiber 855 N. Wolfe Street Suite 623 BALTIMORE MD MARYLAND 21205 Director Joshua Silverman 855 N. Wolfe Street Suite 623 BALTIMORE MD MARYLAND 21205 Director Jude Uzonwanne 855 N. Wolfe Street Suite 623 BALTIMORE MD MARYLAND 21205 Director Bill J. White 855 N. Wolfe Street Suite 623 BALTIMORE MD MARYLAND 21205 Director Mitchell Glass 855 N. Wolfe Street Suite 623 BALTIMORE MD MARYLAND 21205 Director Pharmaceuticals Decline to Disclose 06b false 2024-05-20 false true true true false 0 Palladium Capital Group, LLC 000129400 None None 152 West 57th Street 22nd Floor New York NY NEW YORK 10019 NY NEW YORK false GP Nurmenkari Inc. 000153480 None None 22 Elizabeth Street Norwalk CT CONNECTICUT 06854 NY NEW YORK CT CONNECTICUT false 26850006 26850006 0 Includes aggregate exercise price of warrants of $1.816 (subject to price-based adjustment), that may be received upon exercise of the warrants false 4 537000 0 Issuer issued to placement agents (or their designees) warrants to purchase up to 887,114 shares at an exercise price of $1.816 (subject to price-based adjustment) under Section 4(a)(2) 0 false MyMD Pharmaceuticals, Inc. /s/ Chris Chapman Chris Chapman President and Chief Medical Officer 2024-05-31